Shu-chih Chen - Net Worth and Insider Trading
Shu-chih Chen Net Worth
The estimated net worth of Shu-chih Chen is at least $36,100 dollars as of 2024-11-08. Shu-chih Chen is the Director, 10% Owner of Atossa Therapeutics Inc and owns about 24,157 shares of Atossa Therapeutics Inc (ATOS) stock worth over $36,100. Details can be seen in Shu-chih Chen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shu-chih Chen has not made any transactions after 2016-03-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shu-chih Chen
Shu-chih Chen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shu-chih Chen owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .
Click here to see the complete history of Shu-chih Chen’s form 4 insider trades.
Insider Ownership Summary of Shu-chih Chen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | director & 10 percent owner & Chief Scientific Officer |
Shu-chih Chen Latest Holdings Summary
Shu-chih Chen currently owns a total of 1 stock. Shu-chih Chen owns 24,157 shares of Atossa Therapeutics Inc (ATOS) as of March 9, 2016, with a value of $36,100.
Latest Holdings of Shu-chih Chen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | 24,157 | 1.49 | 36,100 |
Holding Weightings of Shu-chih Chen
Shu-chih Chen Form 4 Trading Tracker
According to the SEC Form 4 filings, Shu-chih Chen has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 83 shares on March 9, 2016, which cost Shu-chih Chen around $5,550.
Insider Trading History of Shu-chih Chen
- 1
Shu-chih Chen Trading Performance
GuruFocus tracks the stock performance after each of Shu-chih Chen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shu-chih Chen is -5.45%. GuruFocus also compares Shu-chih Chen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shu-chih Chen within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shu-chih Chen's insider trading performs compared to the benchmark.
Performance of Shu-chih Chen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 41.06 | | | | | |
| Relative Return to S&P 500(%) | 37.12 | | | | | |
Shu-chih Chen Ownership Network
Ownership Network List of Shu-chih Chen
Ownership Network Relation of Shu-chih Chen
Shu-chih Chen Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Shu-chih Chen is the director & 10 percent owner & Chief Scientific Officer of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & CEO Steven C Quay .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Shu-chih Chen made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Shu-chih Chen Mailing Address
Above is the net worth, insider trading, and ownership report for Shu-chih Chen. You might contact Shu-chih Chen via mailing address: C/o Atossa Genetics, Inc, 4105 E Madison Street, Suite 320, Seattle Wa 98112.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
